James R Musick insider trades: Vitro Diagnostics (VODG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 23, 2014 | VODG | ↓ Sell | 5,000 | $0.14 | $700 | Direct | Sep 24, 2014 (1d) |
| Aug 28, 2009 | VODG | ↓ Sell | 42,000 | $0.29 | $12K | James R. Musick Trust, James R. Musick, | Aug 31, 2009 (3d) |
| Feb 12, 2009 | VODG | ↑ Buy | 226,667 | $0.04 | $9K | James R. Musick Trust; James R. Musick, | Jul 13, 2009 (151d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James R Musick's insider trades
James R Musick is President, CEO at Vitro Diagnostics (VODG). Since Feb 12, 2009, James has reported 1 open-market purchase worth $9K and 2 sales worth $13K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VODG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.